Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 621 - 640 of 1970 results

Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives.

Fisher, David E. ;

Geller, Alan C.

April 2025 | The Journal of Investigative Dermatology, 2025, v. 145, no. 4

Indoor tanning is universally considered to be an important cause of melanoma and keratinocyte carcinomas. Pooling together more than 406,000 individuals from 88 studies, Wehner et al found that more than 450 000 NMSC cases and more than 10 000 melanoma cases each year were attributable to indoor tanning in the United States, Europe, and Australia. ...

10/09/2026

Supporting Files

Title : Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives. Personal Author(s) : Fisher, David E.;Geller, Alan C.; Published Date : April 2025 Pages in Document : 721-723 (4 pdf pages) Source : The Journal of Investigative Dermatology, 2025, v. 145, no. 4 DOI : https://doi.org/10.1016/j.jid.2024.05.037 Journal Title : The Journal of Investigative Dermatology
Fisher, D. E., & Geller, A. C. (2025). Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives. The Journal of Investigative Dermatology, 145(4). https://doi.org/10.1016/j.jid.2024.05.037

Fisher, David E. and Alan C. Geller. "Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives." The Journal of Investigative Dermatology 145, no. 4 (2025). https://doi.org/10.1016/j.jid.2024.05.037.

Fisher, David E., and Alan C. Geller "Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives." The Journal of Investigative Dermatology, vol. 145, no. 4, 2025. Stacks. https://doi.org/10.1016/j.jid.2024.05.037.
Export RIS Citation Information. TY - Journal Article AU - Fisher, David E. AU - Geller, Alan C. AB - Indoor tanning is universally considered to be an important cause of melanoma and keratinocyte carcinomas. Pooling together more than 406,000 individuals from 88 studies, Wehner et al found that more than 450 000 NMSC cases and more than 10 000 melanoma cases each year were attributable to indoor tanning in the United States, Europe, and Australia. 1 AB - Mechanistically, it is well documented that both UVA and UVB wavelengths trigger mutagenic changes in the genomes of skin cells. Moreover, the UV/tanning pathway has been shown to directly stimulate cutaneous synthesis of b-endorphin and to cause addiction-like behavioral changes. UV or sun-seeking risk may therefore be compelled by conscious or even unconscious behavioral influences, which may include ease of access to sources of UV-tanning.2 AB - Two economic models, one from the United States and the second from the UK both concluded that restricting or banning indoor tanning would result in fewer skin cancer cases and deaths. In the United States, restricting indoor tanning among minors younger than 18 years could prevent 61,839 melanoma cases, prevent 6735 melanoma deaths, and save $342.9 million in treatment costs over the lifetime of the 61.2 million youth age 14 years or younger. The projected health and economic benefits increased as indoor tanning were further reduced.3 Compared with the current lack of a consistent policy, a ban on commercial indoor tanning combined with a public information campaign would result in 1206 preventable cases of melanoma, 207 fewer melanoma deaths and 3987 averted cases of keratinocyte cancers over the lifetime of all 18-year-olds (n = 618 873) living in England in 2019. At a cost-effectiveness threshold of £20 000, they determined that there is a 99% likelihood of this policy-based intervention being cost-effective AB - Author manuscript AN - cdc:261643 C4 - PMC12153046 DO - https://doi.org/10.1016/j.jid.2024.05.037 IS - 4 J2 - The Journal of Investigative Dermatology KW - Keratinocytes KW - Models, Economic KW - Carcinoma KW - Endorphins KW - Cost-Benefit Analysis KW - Policy KW - Melanoma KW - Health Care Costs KW - Cost-Benefit Analysis KW - Melanoma KW - Models, Economic KW - Health Care Costs KW - Keratinocytes KW - Carcinoma KW - Endorphins KW - Policy LA - eng PY - 2025 T2 - The Journal of Investigative Dermatology T2 - The Journal of Investigative Dermatology, 2025, v. 145, no. 4 TI - Tans, Bans, and Sedans: How Distance From Tanning Beds May Save Lives. VL - 145 UR - https://stacks.cdc.gov/view/cdc/261643 ER -
Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen.

Ng, Amanda E. ;

Swedo, Elizabeth

May 2025 | Child Abuse & Neglect, 2025, v. 163

Parent-reported surveys are commonly used in child health research. However, few national surveys have examined concordance between parent- and teen-reported Adverse Childhood Experiences (ACEs).To examine concordance between parent- and teen-reported ACEs among a nationally representative sample of teens and understand sociodemographic correlates ...

10/09/2026

Supporting Files

Title : Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen. Personal Author(s) : Ng, Amanda E.;Swedo, Elizabeth;Zablotsky, Benjamin;Black, Lindsey I.;Niolon, Phyllis Holditch;Bose, Jonaki;Blumberg, Stephen J.; Published Date : May 2025 Pages in Document : 107339 (19 pdf pages) Source : Child Abuse & Neglect, 2025, v. 163 DOI : https://doi.org/10.1016/j.chiabu.2025.107339 Journal Title : Child Abuse & Neglect
Ng, A. E., Swedo, E., Zablotsky, B., Black, L. I., Niolon, P. H., Bose, J., & Blumberg, S. J. (2025). Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen. Child Abuse & Neglect, 163. https://doi.org/10.1016/j.chiabu.2025.107339

Ng, Amanda E., Elizabeth Swedo, Benjamin Zablotsky, Lindsey I. Black, Phyllis Holditch Niolon, Jonaki Bose, and Stephen J. Blumberg. "Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen." Child Abuse & Neglect 163 (2025). https://doi.org/10.1016/j.chiabu.2025.107339.

Ng, Amanda E., et al. "Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen." Child Abuse & Neglect, vol. 163, 2025. Stacks. https://doi.org/10.1016/j.chiabu.2025.107339.
Export RIS Citation Information. TY - Journal Article AU - Ng, Amanda E. AU - Swedo, Elizabeth AU - Zablotsky, Benjamin AU - Black, Lindsey I. AU - Niolon, Phyllis Holditch AU - Bose, Jonaki AU - Blumberg, Stephen J. AB - Parent-reported surveys are commonly used in child health research. However, few national surveys have examined concordance between parent- and teen-reported Adverse Childhood Experiences (ACEs). AB - To examine concordance between parent- and teen-reported ACEs among a nationally representative sample of teens and understand sociodemographic correlates of concordance. AB - Data were collected as part of the National Health Interview Survey (NHIS), an annual nationally representative survey of the United States, with parent-reported interviews and its follow-back survey, the National Health Interview Survey-Teen (NHIS-Teen), a self-administered web survey of youth aged 12-17 years. AB - Parent- and teen-reported ACEs, and several measures of concordance (e.g. weighted Cohen's kappa, prevalence adjusted bias adjusted kappa (PABAK)) are presented. Unadjusted logistic regressions tested associations between sociodemographic characteristics and likelihood of concordance for each ACE. AB - ACEs prevalence based on parent report were lower compared to teen report (e.g. victim of or witnessed violence in the neighborhood, 6.5 % parent-reported vs. 15.5 %, teen-reported). Weighted Cohen's kappa statistics showed fair to moderate agreement (ks ranging from 0.27 to 0.53), with PABAK statistics showing slightly higher levels (ks ranging from 0.41 to 0.88). AB - There is discordance in ACEs reporting between teens and their parents, with parents less likely to report that their teen experience an ACE than teens are. This emphasizes the importance of collecting information directly from teenagers, which may help inform intervention work. AB - Author manuscript AN - cdc:261642 C4 - PMC12129094 DO - https://doi.org/10.1016/j.chiabu.2025.107339 J2 - Child Abuse & Neglect KW - Adolescent KW - Child KW - Adverse Childhood Experiences KW - Female KW - Parents KW - Male KW - Humans KW - Child Abuse KW - Health Surveys KW - Adolescent health KW - Adverse childhood experiences KW - Concordance KW - National Health Interview Survey KW - National Health Interview Survey-Teen KW - Social determinants of health KW - Humans KW - Adolescent KW - Female KW - Male KW - Adverse Childhood Experiences KW - Child KW - Parents KW - Health Surveys KW - Child Abuse LA - eng PY - 2025 T2 - Child Abuse & Neglect T2 - Child Abuse & Neglect, 2025, v. 163 TI - Parent-teen Concordance of Selected Adverse Childhood Experiences in a National Sample of Teenagers: Findings From National Health Interview Survey - Teen. VL - 163 UR - https://stacks.cdc.gov/view/cdc/261642 ER -
Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization.

Lyle, Alicia N. ;

Danilenko, Uliana I.

June 2025 | Critical Reviews in Clinical Laboratory Sciences, 2025, v. 62, no. 4

Cardiovascular disease (CVD) is the leading cause of mortality in the United States and globally. This review describes changes in CVD lipid and lipoprotein biomarker measurements that occurred in line with the evolution of clinical practice guidelines for CVD risk assessment and treatment. It also discusses the level of comparability of these biom ...

10/09/2026

Supporting Files

Title : Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization. Personal Author(s) : Lyle, Alicia N.;Danilenko, Uliana I.;Sugahara, Otoe;Vesper, Hubert W.; Published Date : June 2025 Pages in Document : 266-287 (37 pdf pages) Source : Critical Reviews in Clinical Laboratory Sciences, 2025, v. 62, no. 4 DOI : https://doi.org/10.1080/10408363.2025.2462817 Journal Title : Critical Reviews in Clinical Laboratory Sciences
Lyle, A. N., Danilenko, U. I., Sugahara, O., & Vesper, H. W. (2025). Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization. Critical Reviews in Clinical Laboratory Sciences, 62(4). https://doi.org/10.1080/10408363.2025.2462817

Lyle, Alicia N., Uliana I. Danilenko, Otoe Sugahara, and Hubert W. Vesper. "Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization." Critical Reviews in Clinical Laboratory Sciences 62, no. 4 (2025). https://doi.org/10.1080/10408363.2025.2462817.

Lyle, Alicia N., et al. "Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization." Critical Reviews in Clinical Laboratory Sciences, vol. 62, no. 4, 2025. Stacks. https://doi.org/10.1080/10408363.2025.2462817.
Export RIS Citation Information. TY - Journal Article AU - Lyle, Alicia N. AU - Danilenko, Uliana I. AU - Sugahara, Otoe AU - Vesper, Hubert W. AB - Cardiovascular disease (CVD) is the leading cause of mortality in the United States and globally. This review describes changes in CVD lipid and lipoprotein biomarker measurements that occurred in line with the evolution of clinical practice guidelines for CVD risk assessment and treatment. It also discusses the level of comparability of these biomarker measurements in clinical practice. Comparable and reliable measurements are achieved through assay standardization, which not only depends on correct test calibration but also on factors such as analytical sensitivity, selectivity, susceptibility to factors that can affect the analytical measurement process, and the stability of the test system over time. The current status of standardization for traditional and newer CVD biomarkers is discussed, as are approaches to setting and achieving standardization goals for low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglycerides (TG), lipoprotein(a) (Lp(a)), apolipoproteins (apo) A-I and B, and non-HDL-C. Appropriate levels of standardization for blood lipids are maintained by the Centers for Disease Control and Prevention's (CDC) CVD Biomarkers Standardization Program (CDC CVD BSP) using the analytical performance goals recommended by the National Cholesterol Education Program. The level of measurement agreement that can be achieved is dependent on the characteristics of the analytes and differences in measurement principles between reference measurement procedures and clinical assays. The technical and analytical limitations observed with traditional blood lipids are not observed with apolipoproteins. Additionally, apoB and Lp(a) may more accurately capture CVD risk and residual CVD risk, respectively, than traditional lipids, thus prompting current guidelines to recommend apolipoprotein measurements. This review further discusses CDC's approach to standardization and describes the analytical performance of traditional blood lipids and apoA-I and B observed over the past 11 years. The reference systems for apoA-I and B, previously maintained by a single laboratory, no longer exist, thus requiring the creation of new systems, which is currently underway. This situation emphasizes the importance of a collaborative network of laboratories, such as CDC's Cholesterol Reference Methods Laboratory Network (CRMLN), to ensure standardization sustainability. CDC is supporting the International Federation of Clinical Chemistry and Laboratory Medicine's (IFCC) work to establish such a network for lipoproteins. Ensuring comparability and reliability of CVD biomarker measurements through standardization remains critical for the effective implementation of clinical practice guidelines and for improving patient care. Utilizing experience gained over three decades, CDC CVD BSP will continue to improve the standardization of traditional and emerging CVD biomarkers together with stakeholders. AB - Author manuscript AN - cdc:261641 C4 - PMC13126338 DO - https://doi.org/10.1080/10408363.2025.2462817 IS - 4 J2 - Critical Reviews in Clinical Laboratory Sciences KW - Biomarkers KW - Lipids KW - Cardiovascular Diseases KW - Lipoproteins KW - Humans KW - Reference Standards KW - Standardization KW - lipids KW - cardiovascular disease biomarkers KW - apolipoproteins KW - lipoprotein(a) KW - Humans KW - Cardiovascular Diseases KW - Biomarkers KW - Lipoproteins KW - Lipids KW - Reference Standards LA - eng PY - 2025 T2 - Critical Reviews in Clinical Laboratory Sciences T2 - Critical Reviews in Clinical Laboratory Sciences, 2025, v. 62, no. 4 TI - Cardiovascular Disease Lipids and Lipoproteins Biomarker Standardization. VL - 62 UR - https://stacks.cdc.gov/view/cdc/261641 ER -
Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019.

Galindo, Maureen K. ;

Klewer, Scott E.

April 23, 2025 | Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health, 2025, v. 35, no. 2

Guidelines recommend tailored reproductive health counseling for women with congenital heart defects (CHDs) beginning in adolescence, yet provider adherence to recommendations remains understudied, particularly outside specialized cardiac care settings.We conducted a cross-sectional cohort study among women aged 19 to 38 with CHDs, identified from ...

10/09/2026

Supporting Files

Title : Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019. Personal Author(s) : Galindo, Maureen K.;Klewer, Scott E.;Downing, Karrie F.;Takamatsu, Chelsea L.;Seckeler, Michael D.;Oster, Matthew E.;Collins, R. Thomas;Nembhard, Wendy N.;Bolin, Elijah H.;Farr, Sherry L.; Published Date : April 23, 2025 Pages in Document : 65-73 (19 pdf pages) Source : Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health, 2025, v. 35, no. 2 DOI : https://doi.org/10.1016/j.whi.2025.01.005 Journal Title : Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
Galindo, M. K., Klewer, S. E., Downing, K. F., Takamatsu, C. L., Seckeler, M. D., Oster, M. E., Collins, R. T., Nembhard, W. N., Bolin, E. H., & Farr, S. L. (2025). Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019. Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health, 35(2). https://doi.org/10.1016/j.whi.2025.01.005

Galindo, Maureen K., Scott E. Klewer, Karrie F. Downing, Chelsea L. Takamatsu, Michael D. Seckeler, Matthew E. Oster, R. Thomas Collins, Wendy N. Nembhard, Elijah H. Bolin, and Sherry L. Farr. "Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019." Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 35, no. 2 (2025). https://doi.org/10.1016/j.whi.2025.01.005.

Galindo, Maureen K., et al. "Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019." Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health, vol. 35, no. 2, 2025. Stacks. https://doi.org/10.1016/j.whi.2025.01.005.
Export RIS Citation Information. TY - Journal Article AU - Galindo, Maureen K. AU - Klewer, Scott E. AU - Downing, Karrie F. AU - Takamatsu, Chelsea L. AU - Seckeler, Michael D. AU - Oster, Matthew E. AU - Collins, R. Thomas AU - Nembhard, Wendy N. AU - Bolin, Elijah H. AU - Farr, Sherry L. AB - Guidelines recommend tailored reproductive health counseling for women with congenital heart defects (CHDs) beginning in adolescence, yet provider adherence to recommendations remains understudied, particularly outside specialized cardiac care settings. AB - We conducted a cross-sectional cohort study among women aged 19 to 38 with CHDs, identified from active population-based birth defects registries in three states. Participants completed surveys from 2016 to 2019, including questions about contraception, pregnancy counseling, concerns, and experiences. Multivariable Poisson regression, adjusted for sociodemographic and health characteristics, assessed associations between CHD severity, counseling, and reproductive health outcomes. AB - Of 765 women, those with severe CHDs, compared with non-severe, were more likely to report receiving clinician counseling about safe contraceptive methods (44.0% and 13.7%; adjusted prevalence ratio [aPR] = 3.0; 95% confidence interval [95% CI] [2.2, 4.0]), pregnancy, (63.3% and 16.5%; aPR = 3.6; 95% CI [2.7, 4.6]), and pregnancy avoidance (32.0% and 6.4%; aPR = 4.3; 95% CI [2.9, 6.6]); be concerned about ability to have children (40.9% and 31.2%; aPR = 1.4; 95% CI [1.1, 1.8]), and delay/avoid pregnancy (26.6% and 10.7%; aPR = 2.2; 95% CI [1.5, 3.2]). No disparity was found in ever being pregnant (30.0% vs. 37.2%; aPR = 1.0; 95% CI [0.7, 1.2]). One-third of the respondents with any CHD reported concerns about their ability to have children (33.6%). AB - We found that only a minority of women with CHDs reported receiving counseling on safe contraception and pregnancy, and about a third reported concerns about their ability to have children. These findings highlight a gap between guideline recommendations and clinical practice, underscoring the need for improved reproductive health discussions for women with CHDs. AB - Author manuscript AN - cdc:261640 C4 - PMC12017272 DO - https://doi.org/10.1016/j.whi.2025.01.005 IS - 2 J2 - Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health KW - Pregnancy KW - Cohort Studies KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - Female KW - Counseling KW - Heart Defects, Congenital KW - Reproductive Health KW - Humans KW - Young Adult KW - Contraception KW - Adult KW - Humans KW - Female KW - Adult KW - Heart Defects, Congenital KW - Counseling KW - Cross-Sectional Studies KW - Reproductive Health KW - Pregnancy KW - Contraception KW - Young Adult KW - Surveys and Questionnaires KW - Cohort Studies LA - eng PY - 2025 T2 - Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health T2 - Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health, 2025, v. 35, no. 2 TI - Reproductive Health Counseling and Outcomes Among Women With Congenital Heart Defects: Results From the Congenital Heart Survey to Recognize Outcomes, Needs, and Well-Being, 2016-2019. VL - 35 UR - https://stacks.cdc.gov/view/cdc/261640 ER -
Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay.

Fu, Yonghao ;

Song, Yang

August 2025 | Talanta, 2025, v. 291

Exposure to wood smoke is associated with various adverse health problems. Biomonitoring of smoke exposure-associated biomarkers provides accurate measurements of personally absorbed doses. As a specific metabolite of benzene, the quantitative measurement of S-phenylmercapturic acid (S-PMA) plays a vital role in evaluating human exposure to wood sm ...

10/09/2026

Supporting Files

Title : Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay. Personal Author(s) : Fu, Yonghao;Song, Yang;Yang, Zhansen;Ruan, Xiaofan;Lin, Yuehe;Du, Dan; Published Date : August 2025 Pages in Document : 127760 (23 pdf pages) Source : Talanta, 2025, v. 291 DOI : https://doi.org/10.1016/j.talanta.2025.127760 Journal Title : Talanta
Fu, Y., Song, Y., Yang, Z., Ruan, X., Lin, Y., & Du, D. (2025). Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay. Talanta, 291. https://doi.org/10.1016/j.talanta.2025.127760

Fu, Yonghao, Yang Song, Zhansen Yang, Xiaofan Ruan, Yuehe Lin, and Dan Du. "Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay." Talanta 291 (2025). https://doi.org/10.1016/j.talanta.2025.127760.

Fu, Yonghao, et al. "Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay." Talanta, vol. 291, 2025. Stacks. https://doi.org/10.1016/j.talanta.2025.127760.
Export RIS Citation Information. TY - Journal Article AU - Fu, Yonghao AU - Song, Yang AU - Yang, Zhansen AU - Ruan, Xiaofan AU - Lin, Yuehe AU - Du, Dan AB - Exposure to wood smoke is associated with various adverse health problems. Biomonitoring of smoke exposure-associated biomarkers provides accurate measurements of personally absorbed doses. As a specific metabolite of benzene, the quantitative measurement of S-phenylmercapturic acid (S-PMA) plays a vital role in evaluating human exposure to wood smoke. In this study, we developed an efficient lateral flow immunoassay (LFIA) approach for accurately and rapidly measuring S-PMA levels. Europium chelate nanoparticles (EuNPs) conjugated with purified polyclonal sheep anti-S-PMA antibodies were employed as the fluorescent detection probe. This work is based on a competitive immunoassay, where the target S-PMA competes with the immobilized antigen on the test lines for the limited antigen-binding sites on EuNP-conjugated antibodies. Due to this competition, the fluorescent intensity of the EuNPs is inversely proportional to the concentration of the target S-PMA in the sample, enabling quantitative measurement. Owing to the large Stokes shift, superior fluorescent brightness, and saturation of the EuNPs, S-PMA levels can be measured with a limit of detection of 0.32 ng/mL, a detectable range of 0.10-30 ng/mL, and a linear detection range of 0.25-30 ng/mL under optimized conditions. Stability testing revealed that the LFIA strips can be stored at room temperature for up to one year while maintaining excellent detection performance for S-PMA. These results demonstrate that the EuNP-based LFIA is a promising tool for accurate preclinical and point-of-care evaluation of wood smoke exposure. A major advantage of this approach is its ability to accurately analyze smoke biomarkers at anticipated low concentrations. The sensor system allows low-cost, rapid, and on-site data collection and quantification of wood smoke exposure. AB - Author manuscript AN - cdc:261639 C4 - PMC12011643 DO - https://doi.org/10.1016/j.talanta.2025.127760 J2 - Talanta KW - Biomarkers KW - Limit of Detection KW - Wood KW - Fluorescent Dyes KW - Smoke KW - Immunoassay KW - Animals KW - Nanoparticles KW - Humans KW - Europium KW - Lateral flow immunoassay KW - Europium chelates nanoparticles KW - Wood smoke biomarker KW - S-phenylmercapturic acid KW - Biomarkers KW - Wood KW - Smoke KW - Europium KW - Immunoassay KW - Fluorescent Dyes KW - Nanoparticles KW - Humans KW - Limit of Detection KW - Animals LA - eng PY - 2025 T2 - Talanta T2 - Talanta, 2025, v. 291 TI - Rapid and Sensitive Detection of Wood Smoke Exposure Biomarkers Using Europium Fluorescent Nanoparticle Label/lateral Flow Immunoassay. VL - 291 UR - https://stacks.cdc.gov/view/cdc/261639 ER -
Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020.

Patrick, Mary E. ;

Williams, Ashley Robinson

April 2025 | Annals of Epidemiology, 2025, v. 104

The Autism and Developmental Disabilities Monitoring (ADDM) Network estimates the prevalence of autism spectrum disorder (ASD) throughout the United States. Reports through 2010 found higher prevalence in areas of higher socioeconomic status. Reports since 2018 indicate a pattern change. We used CDC's Social Vulnerability Index (SVI) to examine the ...

10/09/2026

Supporting Files

Title : Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020. Personal Author(s) : Patrick, Mary E.;Williams, Ashley Robinson;Shaw, Kelly A.;Durkin, Maureen;Hall-Lande, Jennifer;Vehorn, Alison;Hughes, Michelle; Published Date : April 2025 Pages in Document : 8-14 (16 pdf pages) Source : Annals of Epidemiology, 2025, v. 104 DOI : https://doi.org/10.1016/j.annepidem.2025.02.014 Journal Title : Annals of Epidemiology
Patrick, M. E., Williams, A. R., Shaw, K. A., Durkin, M., Hall-Lande, J., Vehorn, A., & Hughes, M. (2025). Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020. Annals of Epidemiology, 104. https://doi.org/10.1016/j.annepidem.2025.02.014

Patrick, Mary E., Ashley Robinson Williams, Kelly A. Shaw, Maureen Durkin, Jennifer Hall-Lande, Alison Vehorn, and Michelle Hughes. "Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020." Annals of Epidemiology 104 (2025). https://doi.org/10.1016/j.annepidem.2025.02.014.

Patrick, Mary E., et al. "Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020." Annals of Epidemiology, vol. 104, 2025. Stacks. https://doi.org/10.1016/j.annepidem.2025.02.014.
Export RIS Citation Information. TY - Journal Article AU - Patrick, Mary E. AU - Williams, Ashley Robinson AU - Shaw, Kelly A. AU - Durkin, Maureen AU - Hall-Lande, Jennifer AU - Vehorn, Alison AU - Hughes, Michelle AB - The Autism and Developmental Disabilities Monitoring (ADDM) Network estimates the prevalence of autism spectrum disorder (ASD) throughout the United States. Reports through 2010 found higher prevalence in areas of higher socioeconomic status. Reports since 2018 indicate a pattern change. We used CDC's Social Vulnerability Index (SVI) to examine the association of ASD prevalence and social vulnerability in ADDM Network sites. AB - Cases of ASD among 8-year-old children in 2020 were linked to SVI measures and population estimates. Tracts were categorized into tertiles (high, medium, and low) and prevalence, prevalence ratios (PRs), and 95 % confidence intervals (CIs) were calculated. AB - Among 5998 children with ASD, we saw higher ASD prevalence in areas with high versus low vulnerability overall (26.18 per 1000; PR=1.06 (1.00-1.13)) and in areas with more minority residents (28.28 per 1000; PR=1.29 (1.21-1.38)), less transportation (27.32 per 1000; PR=1.13 (1.06-1.20)), and greater disability (26.83 per 1000; PR=1.09 (1.02-1.17)). This pattern was observed among White children (PR=1.48 {1.36-1.60}) but reversed among Black (PR=0.61 {0.53-0.70}), Asian (PR=0.58 {0.46-0.73}), and Hispanic (PR=0.83 {0.72-0.95}) children. AB - Disparities in prevalence of ASD by neighborhood-level social vulnerability persist. Directing resources toward providing equitable access to healthcare and support services could help close this gap. AB - Author manuscript AN - cdc:261638 C4 - PMC12004243 DO - https://doi.org/10.1016/j.annepidem.2025.02.014 J2 - Annals of Epidemiology KW - Child KW - Female KW - Autism Spectrum Disorder KW - Social Vulnerability KW - Prevalence KW - Male KW - Humans KW - Developmental Disabilities KW - Socioeconomic Factors KW - Autism spectrum disorder KW - ADDM KW - Prevalence KW - Social Vulnerability KW - Humans KW - Autism Spectrum Disorder KW - Child KW - Prevalence KW - Male KW - Female KW - Social Vulnerability KW - Developmental Disabilities KW - Socioeconomic Factors LA - eng PY - 2025 T2 - Annals of Epidemiology T2 - Annals of Epidemiology, 2025, v. 104 TI - Social Vulnerability and the Prevalence of Autism Spectrum Disorder Among 8-year-old Children, Autism and Developmental Disabilities Monitoring Network, 2020. VL - 104 UR - https://stacks.cdc.gov/view/cdc/261638 ER -
Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season.

Huynh, Cam-Van T. ;

Haanschoten, Emily

April 2025 | Infection Control and Hospital Epidemiology, 2025, v. 46, no. 4

We examined the association between influenza vaccination policies at acute care hospitals and influenza vaccination coverage among healthcare personnel for the 2021-22 influenza season. Mandatory vaccination and masking for unvaccinated personnel were associated with increased odds of vaccination. Hospital employees had higher vaccination coverage ...

10/09/2026

Supporting Files

Title : Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season. Personal Author(s) : Huynh, Cam-Van T.;Haanschoten, Emily;Soe, Minn M.;Barbre, Kira;Meng, Lu;Edwards, Jonathan R.;Kalayil, Elizabeth J.;Lindley, Megan C.;Reses, Hannah E.;Kuhar, David T.;Stuckey, Matthew J.;Benin, Andrea;Bell, Jeneita M.; Published Date : April 2025 Pages in Document : 431-435 (9 pdf pages) Source : Infection Control and Hospital Epidemiology, 2025, v. 46, no. 4 DOI : https://doi.org/10.1017/ice.2025.24 Journal Title : Infection Control and Hospital Epidemiology
Huynh, C. V. T., Haanschoten, E., Soe, M. M., Barbre, K., Meng, L., Edwards, J. R., Kalayil, E. J., Lindley, M. C., Reses, H. E., Kuhar, D. T., Stuckey, M. J., Benin, A., & Bell, J. M. (2025). Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season. Infection Control and Hospital Epidemiology, 46(4). https://doi.org/10.1017/ice.2025.24

Huynh, Cam-Van T., Emily Haanschoten, Minn M. Soe, Kira Barbre, Lu Meng, Jonathan R. Edwards, and Elizabeth J. Kalayil, et al.. "Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season." Infection Control and Hospital Epidemiology 46, no. 4 (2025). https://doi.org/10.1017/ice.2025.24.

Huynh, Cam-Van T., et al. "Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season." Infection Control and Hospital Epidemiology, vol. 46, no. 4, 2025. Stacks. https://doi.org/10.1017/ice.2025.24.
Export RIS Citation Information. TY - Journal Article AU - Huynh, Cam-Van T. AU - Haanschoten, Emily AU - Soe, Minn M. AU - Barbre, Kira AU - Meng, Lu AU - Edwards, Jonathan R. AU - Kalayil, Elizabeth J. AU - Lindley, Megan C. AU - Reses, Hannah E. AU - Kuhar, David T. AU - Stuckey, Matthew J. AU - Benin, Andrea AU - Bell, Jeneita M. AB - We examined the association between influenza vaccination policies at acute care hospitals and influenza vaccination coverage among healthcare personnel for the 2021-22 influenza season. Mandatory vaccination and masking for unvaccinated personnel were associated with increased odds of vaccination. Hospital employees had higher vaccination coverage than licensed independent practitioners. AB - Author manuscript AN - cdc:261637 C4 - PMC12353221 DO - https://doi.org/10.1017/ice.2025.24 IS - 4 J2 - Infection Control and Hospital Epidemiology KW - Female KW - Vaccination KW - Hospitals KW - Personnel, Hospital KW - Male KW - Humans KW - Health Personnel KW - Vaccination Coverage KW - Influenza Vaccines KW - Adult KW - Influenza, Human KW - Influenza vaccination KW - Healthcare Personnel KW - Acute Care Hospitals KW - Humans KW - Influenza, Human KW - Influenza Vaccines KW - Vaccination KW - Personnel, Hospital KW - Vaccination Coverage KW - Health Personnel KW - Hospitals KW - Female KW - Adult KW - Male LA - eng PY - 2025 T2 - Infection Control and Hospital Epidemiology T2 - Infection Control and Hospital Epidemiology, 2025, v. 46, no. 4 TI - Association of Facility Vaccination Policy With Influenza Vaccination Among Healthcare Personnel in Acute Care Hospitals: National Healthcare Safety Network, 2021-22 Influenza Season. VL - 46 UR - https://stacks.cdc.gov/view/cdc/261637 ER -
An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities.

Chesson, Harrell W. ;

Williams, Austin M.

August 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 8

This article describes an updated spreadsheet tool that sexually transmitted infection (STI) prevention programs in the United States can use to estimate the health and economic benefits of their STI and HIV prevention activities.The development of the updated tool, Sexually Transmitted Infection Costs (STIC) Figure 2.0, involved 2 main components. ...

10/09/2026

Supporting Files

Title : An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities. Personal Author(s) : Chesson, Harrell W.;Williams, Austin M.;Ansari, Bahareh;Islam, Md Hafizul;Johnson, Britney L.;Collins, Dayne;Gift, Thomas L.;Martin, Erika G.; Published Date : August 2025 Pages in Document : 443-449 (17 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 8 DOI : https://doi.org/10.1097/OLQ.0000000000002147 Journal Title : Sexually Transmitted Diseases
Chesson, H. W., Williams, A. M., Ansari, B., Islam, M. H., Johnson, B. L., Collins, D., Gift, T. L., & Martin, E. G. (2025). An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities. Sexually Transmitted Diseases, 52(8). https://doi.org/10.1097/OLQ.0000000000002147

Chesson, Harrell W., Austin M. Williams, Bahareh Ansari, Md Hafizul Islam, Britney L. Johnson, Dayne Collins, Thomas L. Gift, and Erika G. Martin. "An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities." Sexually Transmitted Diseases 52, no. 8 (2025). https://doi.org/10.1097/OLQ.0000000000002147.

Chesson, Harrell W., et al. "An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities." Sexually Transmitted Diseases, vol. 52, no. 8, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002147.
Export RIS Citation Information. TY - Journal Article AU - Chesson, Harrell W. AU - Williams, Austin M. AU - Ansari, Bahareh AU - Islam, Md Hafizul AU - Johnson, Britney L. AU - Collins, Dayne AU - Gift, Thomas L. AU - Martin, Erika G. AB - This article describes an updated spreadsheet tool that sexually transmitted infection (STI) prevention programs in the United States can use to estimate the health and economic benefits of their STI and HIV prevention activities. AB - The development of the updated tool, Sexually Transmitted Infection Costs (STIC) Figure 2.0, involved 2 main components. First, we revised the tool to be more useful and user-friendly based on feedback from focus groups and usability testing. Second, we updated the mathematical model behind the calculations by (1) revising the model to reflect current STI and HIV prevention activities in the United States, (2) updating the epidemiological and economic parameters in the model using the best available evidence, and (3) including ranges (not just point estimates) in the model output. To demonstrate the use of STIC Figure 2.0, we applied it to estimate the impact of a hypothetical prevention program, consistent with that of a health department or large STI clinic in a metropolitan area. AB - STIC Figure 2.0 incorporated new features, including an interactive user interface to explore findings and create customized charts for use in reports and presentations. The hypothetical example we analyzed illustrated how providing STI treatment to 2680 people and HIV prevention services to 325 people could avert 1253 adverse outcomes and save more than $2 million in medical costs and productivity costs. AB - Although subject to important limitations, STIC Figure 2.0 allows state and local programs, including STI clinics, to calculate evidence-based estimates of the impact of their program activities. AB - Author manuscript AN - cdc:261636 C4 - PMC12233172 DO - https://doi.org/10.1097/OLQ.0000000000002147 IS - 8 J2 - Sexually Transmitted Diseases KW - Female KW - Sexually Transmitted Diseases KW - Male KW - Humans KW - Cost-Benefit Analysis KW - Health Care Costs KW - HIV Infections KW - cost KW - cost analysis KW - sexually transmitted infections KW - HIV KW - prevention KW - control KW - program evaluation KW - Humans KW - HIV Infections KW - Sexually Transmitted Diseases KW - Cost-Benefit Analysis KW - Female KW - Male KW - Health Care Costs LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 8 TI - An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261636 ER -
Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups.

Carnes, Neal ;

Koenig, Linda J.

April 2026 | Journal of Racial and Ethnic Health Disparities, 2026, v. 13, no. 2

We conducted a demonstration project of telemedicine HIV care services at the University of Florida (UF) College of Medicine, Jacksonville. Our sample focused on members of racial and ethnic minority groups living in an urban setting. As part of the project's evaluation, we conducted 13 focus groups. Focus groups assessed patient, staff, and provid ...

10/09/2026

Supporting Files

Title : Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups. Personal Author(s) : Carnes, Neal;Koenig, Linda J.;Wilkes, Aisha L.;Gelaude, Deborah;Salabarría-Peña, Yamir;Johnston, Marie; Published Date : April 2026 Pages in Document : 1106-1114 (15 pdf pages) Source : Journal of Racial and Ethnic Health Disparities, 2026, v. 13, no. 2 DOI : https://doi.org/10.1007/s40615-025-02319-7 Journal Title : Journal of Racial and Ethnic Health Disparities
Carnes, N., Koenig, L. J., Wilkes, A. L., Gelaude, D., Salabarría-Peña, Y., & Johnston, M. (2026). Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups. Journal of Racial and Ethnic Health Disparities, 13(2). https://doi.org/10.1007/s40615-025-02319-7

Carnes, Neal, Linda J. Koenig, Aisha L. Wilkes, Deborah Gelaude, Yamir Salabarría-Peña, and Marie Johnston. "Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups." Journal of Racial and Ethnic Health Disparities 13, no. 2 (2026). https://doi.org/10.1007/s40615-025-02319-7.

Carnes, Neal, et al. "Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups." Journal of Racial and Ethnic Health Disparities, vol. 13, no. 2, 2026. Stacks. https://doi.org/10.1007/s40615-025-02319-7.
Export RIS Citation Information. TY - Journal Article AU - Carnes, Neal AU - Koenig, Linda J. AU - Wilkes, Aisha L. AU - Gelaude, Deborah AU - Salabarría-Peña, Yamir AU - Johnston, Marie AB - We conducted a demonstration project of telemedicine HIV care services at the University of Florida (UF) College of Medicine, Jacksonville. Our sample focused on members of racial and ethnic minority groups living in an urban setting. As part of the project's evaluation, we conducted 13 focus groups. Focus groups assessed patient, staff, and provider experiences with facilitating or hindering factors to engaging in telemedicine. We also explored the decision-making processes among people with HIV (PWH) to engage or not in telemedicine. The 46 focus group participants included 21 PWH: 12 PWH who accepted and nine who declined participation in telemedicine. The remaining 25 focus group participants were comprised of medical, clinical support, and community-based organization staff who supported the demonstration project. An unexpected finding that emerged in the focus group narratives detailed that some PWH who accepted telemedicine visits appreciated that telemedicine minimized the stigma they have experienced during in-person healthcare encounters. Among PWH who declined a telemedicine visit, they felt the extension of service into their personal world invaded their privacy, created routes for stigma should their HIV status be disclosed outside the healthcare setting, and raised concerns about confidentiality in virtual settings. Like the PWH, the professionals were mixed in their opinions in that some felt telemedicine facilitated care while others raised concerns. Findings point to the importance of allowing PWH to select the format (in-person or via telemedicine) in which their HIV care is rendered and highlight the importance of intervening to decrease healthcare facility-based stigma. AB - Author manuscript AN - cdc:261635 C4 - PMC12353379 DO - https://doi.org/10.1007/s40615-025-02319-7 IS - 2 J2 - Journal of Racial and Ethnic Health Disparities KW - Focus Groups KW - Minority Groups KW - Female KW - Qualitative Research KW - Social Stigma KW - Patient Acceptance of Health Care KW - Ethnicity KW - Privacy KW - Male KW - Humans KW - Middle Aged KW - Telemedicine KW - Adult KW - HIV Infections KW - Privacy KW - Stigma KW - Human immunodeficiency virus (HIV) KW - Members of racial and ethnic minority groups KW - Telemedicine KW - Humans KW - Telemedicine KW - HIV Infections KW - Focus Groups KW - Male KW - Female KW - Social Stigma KW - Adult KW - Middle Aged KW - Qualitative Research KW - Minority Groups KW - Ethnicity KW - Privacy KW - Patient Acceptance of Health Care LA - eng PY - 2026 T2 - Journal of Racial and Ethnic Health Disparities T2 - Journal of Racial and Ethnic Health Disparities, 2026, v. 13, no. 2 TI - Addressing Stigma and Privacy Through Telemedicine: Qualitative Findings on Enhancing HIV Care Engagement Among Racial and Ethnic Minority Groups. VL - 13 UR - https://stacks.cdc.gov/view/cdc/261635 ER -
Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset.

Dietlmeier, Julia ;

Greenberg, Benjamin

July 2025 | IEEE Transactions on Bio-Medical Engineering, 2025, v. 72, no. 7

Cochlear implants (CIs) are bionic prostheses that restores hearing via electrical stimulation of the auditory nerve. Hybrid CIs, which use electroacoustic stimulation (EAS), combine residual low-frequency acoustic hearing with CI electrical stimulation. Intracochlear fibrosis, which forms in response to the presence of the implant, may impede resi ...

10/09/2026

Supporting Files

Title : Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset. Personal Author(s) : Dietlmeier, Julia;Greenberg, Benjamin;He, Wenxuan;Wilson, Teresa;Xing, Rubing;Hill, Jordan;Fettig, Adrienne;Otto, Madeline;Rounsavill, Teyhana;Reiss, Lina A. J.;Yi, Jingang;O'Connor, Noel E.;Burwood, George W.S.; Published Date : July 2025 Pages in Document : 2218-2228 (23 pdf pages) Source : IEEE Transactions on Bio-Medical Engineering, 2025, v. 72, no. 7 DOI : https://doi.org/10.1109/TBME.2025.3537868 Journal Title : IEEE Transactions on Bio-Medical Engineering
Dietlmeier, J., Greenberg, B., He, W., Wilson, T., Xing, R., Hill, J., Fettig, A., Otto, M., Rounsavill, T., Reiss, L. A. J., Yi, J., O'Connor, N. E., & Burwood, G. W. (2025). Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset. IEEE Transactions on Bio-Medical Engineering, 72(7). https://doi.org/10.1109/TBME.2025.3537868

Dietlmeier, Julia, Benjamin Greenberg, Wenxuan He, Teresa Wilson, Rubing Xing, Jordan Hill, and Adrienne Fettig, et al.. "Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset." IEEE Transactions on Bio-Medical Engineering 72, no. 7 (2025). https://doi.org/10.1109/TBME.2025.3537868.

Dietlmeier, Julia, et al. "Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset." IEEE Transactions on Bio-Medical Engineering, vol. 72, no. 7, 2025. Stacks. https://doi.org/10.1109/TBME.2025.3537868.
Export RIS Citation Information. TY - Journal Article AU - Dietlmeier, Julia AU - Greenberg, Benjamin AU - He, Wenxuan AU - Wilson, Teresa AU - Xing, Rubing AU - Hill, Jordan AU - Fettig, Adrienne AU - Otto, Madeline AU - Rounsavill, Teyhana AU - Reiss, Lina A. J. AU - Yi, Jingang AU - O'Connor, Noel E. AU - Burwood, George W.S. AB - Cochlear implants (CIs) are bionic prostheses that restores hearing via electrical stimulation of the auditory nerve. Hybrid CIs, which use electroacoustic stimulation (EAS), combine residual low-frequency acoustic hearing with CI electrical stimulation. Intracochlear fibrosis, which forms in response to the presence of the implant, may impede residual hearing function and gradually reduce the efficacy of EAS. It is therefore a translational objective to study the formation of cochlear fibrosis in rodents, with the goal of reducing fibrotic burden and improving outcomes for CI patients. AB - We generate and annotate a novel dataset of optical coherence tomography (OCT) images from chronically implanted Guinea pigs as part of an ongoing study focused on implant induced fibrosis. Objectively assessing fibrotic burden in this model, with high resolution and repeatability, presents an obvious use case for computer vision methods. AB - We present the results of several state-of-the-art semantic segmentation models and compare their efficacy for identifying cochlear fibrosis and other relevant annotations, using a new library of manually segmented OCT images. AB - We find that the best performance is achieved by using a modified version of the well-known UNET architecture (which we term 2D-OCT-UNET) that operates on the upscaled OCT input resolution. AB - For the first time, we have successfully applied computer vision techniques to an OCT dataset of implanted cochleae with fibrosis. Using this deep learning model, the cochlear fibrotic burden calculation can be reliably carried out as we verify in our experimental section. AB - Author manuscript AN - cdc:261634 C4 - PMC12178822 DO - https://doi.org/10.1109/TBME.2025.3537868 IS - 7 J2 - IEEE Transactions on Bio-Medical Engineering KW - Cochlea KW - Hearing Loss KW - Animals KW - Fibrosis KW - Guinea Pigs KW - Tomography, Optical Coherence KW - Cochlear Implants KW - Cochlear fibrosis KW - cochlear implants KW - deep learning KW - residual hearing loss KW - semantic segmentation KW - Animals KW - Tomography, Optical Coherence KW - Guinea Pigs KW - Fibrosis KW - Cochlear Implants KW - Cochlea KW - Hearing Loss LA - eng PY - 2025 T2 - IEEE Transactions on Bio-Medical Engineering T2 - IEEE Transactions on Bio-Medical Engineering, 2025, v. 72, no. 7 TI - Towards Investigating Residual Hearing Loss: Quantification of Fibrosis in a Novel Cochlear OCT Dataset. VL - 72 UR - https://stacks.cdc.gov/view/cdc/261634 ER -
Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Wheeler, Austin M. ;

Baker, Joshua F.

August 2025 | Arthritis & Rheumatology (Hoboken, N.J.), 2025, v. 77, no. 8

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with RA, yet effective risk stratification for RA-ILD is lacking. We sought to characterize unique peripheral blood biomarker signatures in RA that could improve RA-ILD discrimination beyond clinical and genetic risk f ...

10/09/2026

Supporting Files

Title : Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Personal Author(s) : Wheeler, Austin M.;Baker, Joshua F.;Riley, Thomas R.;Johnson, Tate M.;Yang, Yangyuna;Roul, Punyasha;Wysham, Katherine D.;Cannon, Grant W.;Kunkel, Gary;Kerr, Gail;Ascherman, Dana P.;Monach, Paul;Reimold, Andreas;Matson, Scott;Poole, Jill A.;Duryee, Michael J.;Thiele, Geoffrey M.;Mikuls, Ted R.;England, Bryant R.; Published Date : August 2025 Pages in Document : 971-980 (19 pdf pages) Source : Arthritis & Rheumatology (Hoboken, N.J.), 2025, v. 77, no. 8 DOI : https://doi.org/10.1002/art.43149 Journal Title : Arthritis & Rheumatology (Hoboken, N.J.)
Wheeler, A. M., Baker, J. F., Riley, T. R., Johnson, T. M., Yang, Y., Roul, P., Wysham, K. D., Cannon, G. W., Kunkel, G., Kerr, G., Ascherman, D. P., Monach, P., Reimold, A., Matson, S., Poole, J. A., Duryee, M. J., Thiele, G. M., Mikuls, T. R., & England, B. R. (2025). Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis & Rheumatology (Hoboken, N.J.), 77(8). https://doi.org/10.1002/art.43149

Wheeler, Austin M., Joshua F. Baker, Thomas R. Riley, Tate M. Johnson, Yangyuna Yang, Punyasha Roul, and Katherine D. Wysham, et al.. "Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease." Arthritis & Rheumatology (Hoboken, N.J.) 77, no. 8 (2025). https://doi.org/10.1002/art.43149.

Wheeler, Austin M., et al. "Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease." Arthritis & Rheumatology (Hoboken, N.J.), vol. 77, no. 8, 2025. Stacks. https://doi.org/10.1002/art.43149.
Export RIS Citation Information. TY - Journal Article AU - Wheeler, Austin M. AU - Baker, Joshua F. AU - Riley, Thomas R. AU - Johnson, Tate M. AU - Yang, Yangyuna AU - Roul, Punyasha AU - Wysham, Katherine D. AU - Cannon, Grant W. AU - Kunkel, Gary AU - Kerr, Gail AU - Ascherman, Dana P. AU - Monach, Paul AU - Reimold, Andreas AU - Matson, Scott AU - Poole, Jill A. AU - Duryee, Michael J. AU - Thiele, Geoffrey M. AU - Mikuls, Ted R. AU - England, Bryant R. AB - Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with RA, yet effective risk stratification for RA-ILD is lacking. We sought to characterize unique peripheral blood biomarker signatures in RA that could improve RA-ILD discrimination beyond clinical and genetic risk factors. AB - We performed a cross-sectional study of participants in the Veterans Affairs Rheumatoid Arthritis Registry. ILD was validated through systematic record review. Autoantibodies (n = 14), proinflammatory cytokines/chemokines (n = 36), adipokines (n = 3), alarmins (n = 3), and matrix metalloproteinases (n = 9) were measured from banked serum or plasma. MUC5B rs35705950 genotyping was obtained via microarray. Principal component (PC) analysis was performed to derive unique biomarker signatures. Logistic regression was used to compare models predicting RA-ILD presence using combinations of clinical, peripheral biomarker, and genetic variables. AB - Among 2,001 participants with RA (88.7% male, mean age 63.7 years), 121 (6.4%) had RA-ILD. A total of 15 PCs were identified, with 8 significantly associated with RA-ILD after adjusting for clinical factors. These eight included biomarker themes of innate and allergic responses, autoantibodies (anti-cyclic citrullinated peptide, rheumatoid factor, anti-malondialdehyde-acetaldehyde adduct), adipokines, alarmins, tissue remodeling, and neutrophil chemotaxis. Models with PCs (area under the receiver operating characteristic curve [AUC] 0.739) and PCs with MUC5B (AUC 0.751) outperformed clinical risk factors alone (AUC 0.630; P < 0.001). AB - Peripheral biomarker signatures are associated with RA-ILD and improve RA-ILD identification beyond clinical risk factors. In addition to demonstrating the potential for peripheral biomarkers to aid RA-ILD risk stratification, these findings suggest diverse pathways are involved in RA-ILD pathogenesis. AB - Author manuscript AN - cdc:261633 C4 - PMC12311258 DO - https://doi.org/10.1002/art.43149 IS - 8 J2 - Arthritis & Rheumatology (Hoboken, N.J.) KW - Female KW - Mucin-5B KW - Adipokines KW - Aged KW - Cytokines KW - Biomarkers KW - Cross-Sectional Studies KW - Lung Diseases, Interstitial KW - Autoantibodies KW - Matrix Metalloproteinases KW - Male KW - Humans KW - Middle Aged KW - Arthritis, Rheumatoid KW - rheumatoid arthritis KW - interstitial lung disease KW - peripheral biomarkers KW - principal component analysis KW - Humans KW - Male KW - Arthritis, Rheumatoid KW - Female KW - Biomarkers KW - Middle Aged KW - Lung Diseases, Interstitial KW - Cross-Sectional Studies KW - Aged KW - Autoantibodies KW - Mucin-5B KW - Adipokines KW - Cytokines KW - Matrix Metalloproteinases LA - eng PY - 2025 T2 - Arthritis & Rheumatology (Hoboken, N.J.) T2 - Arthritis & Rheumatology (Hoboken, N.J.), 2025, v. 77, no. 8 TI - Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. VL - 77 UR - https://stacks.cdc.gov/view/cdc/261633 ER -
Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing.

Milkovich, Pamela J. ;

McCue, Leigh

July 2025 | Journal of Agromedicine, 2025, v. 30, no. 3

Incubator and accelerator programs are important tools for innovators looking to take their ideas to scale. Unfortunately for agriculture, forestry, and fishing (AgFF) populations who are at high risk for occupational injuries and fatalities, few safety and health solutions have graduated from these programs. This brief report explores what it will ...

10/09/2026

Supporting Files

Title : Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing. Personal Author(s) : Milkovich, Pamela J.;McCue, Leigh;Hirabayashi, Liane;Espejo, Andres Esteban Sandi;Maben, Lance;Sorensen, Julie A.; Published Date : July 2025 Pages in Document : 423-429 (11 pdf pages) Source : Journal of Agromedicine, 2025, v. 30, no. 3 DOI : https://doi.org/10.1080/1059924X.2025.2474711 Journal Title : Journal of Agromedicine
Milkovich, P. J., McCue, L., Hirabayashi, L., Espejo, A. E. S., Maben, L., & Sorensen, J. A. (2025). Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing. Journal of Agromedicine, 30(3). https://doi.org/10.1080/1059924X.2025.2474711

Milkovich, Pamela J., Leigh McCue, Liane Hirabayashi, Andres Esteban Sandi Espejo, Lance Maben, and Julie A. Sorensen. "Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing." Journal of Agromedicine 30, no. 3 (2025). https://doi.org/10.1080/1059924X.2025.2474711.

Milkovich, Pamela J., et al. "Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing." Journal of Agromedicine, vol. 30, no. 3, 2025. Stacks. https://doi.org/10.1080/1059924X.2025.2474711.
Export RIS Citation Information. TY - Journal Article AU - Milkovich, Pamela J. AU - McCue, Leigh AU - Hirabayashi, Liane AU - Espejo, Andres Esteban Sandi AU - Maben, Lance AU - Sorensen, Julie A. AB - Incubator and accelerator programs are important tools for innovators looking to take their ideas to scale. Unfortunately for agriculture, forestry, and fishing (AgFF) populations who are at high risk for occupational injuries and fatalities, few safety and health solutions have graduated from these programs. This brief report explores what it will take to develop an incubator process specific to AgFF safety and health innovations and ensure that those innovations are accessible to and adopted by workers. AB - Author manuscript AN - cdc:261632 C4 - PMC13036584 DO - https://doi.org/10.1080/1059924X.2025.2474711 IS - 3 J2 - Journal of Agromedicine KW - Agriculture KW - Humans KW - Forestry KW - Occupational Injuries KW - Accidents, Occupational KW - Occupational Health KW - Fisheries KW - Customer discovery KW - incubator KW - research to practice (r2p) KW - Humans KW - Occupational Health KW - Agriculture KW - Accidents, Occupational KW - Forestry KW - Fisheries KW - Occupational Injuries LA - eng PY - 2025 T2 - Journal of Agromedicine T2 - Journal of Agromedicine, 2025, v. 30, no. 3 TI - Navigating the Valley of Death : a Brief Report on How Incubators Can Nurture Transition of Research to Practice to Benefit Worker Wellbeing. VL - 30 UR - https://stacks.cdc.gov/view/cdc/261632 ER -
Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records.

Guo, Yuting ;

Shi, Haoming

March 2025 | Birth Defects Research, 2025, v. 117, no. 3

International Classification of Disease (ICD) codes can accurately identify patients with certain congenital heart defects (CHDs). In ICD-defined CHD data sets, the code for secundum atrial septal defect (ASD) is the most common, but it has a low positive predictive value for CHD, potentially resulting in the drawing of erroneous conclusions from s ...

10/09/2026

Supporting Files

Title : Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records. Personal Author(s) : Guo, Yuting;Shi, Haoming;Book, Wendy M.;Ivey, Lindsey Carrie;Rodriguez, Fred H.;Sameni, Reza;Raskind-Hood, Cheryl;Robichaux, Chad;Downing, Karrie F.;Sarker, Abeed; Published Date : March 2025 Pages in Document : e2451 (20 pdf pages) Source : Birth Defects Research, 2025, v. 117, no. 3 DOI : https://doi.org/10.1002/bdr2.2451 Journal Title : Birth Defects Research
Guo, Y., Shi, H., Book, W. M., Ivey, L. C., Rodriguez, F. H., Sameni, R., Raskind-Hood, C., Robichaux, C., Downing, K. F., & Sarker, A. (2025). Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records. Birth Defects Research, 117(3). https://doi.org/10.1002/bdr2.2451

Guo, Yuting, Haoming Shi, Wendy M. Book, Lindsey Carrie Ivey, Fred H. Rodriguez, Reza Sameni, Cheryl Raskind-Hood, Chad Robichaux, Karrie F. Downing, and Abeed Sarker. "Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records." Birth Defects Research 117, no. 3 (2025). https://doi.org/10.1002/bdr2.2451.

Guo, Yuting, et al. "Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records." Birth Defects Research, vol. 117, no. 3, 2025. Stacks. https://doi.org/10.1002/bdr2.2451.
Export RIS Citation Information. TY - Journal Article AU - Guo, Yuting AU - Shi, Haoming AU - Book, Wendy M. AU - Ivey, Lindsey Carrie AU - Rodriguez, Fred H. AU - Sameni, Reza AU - Raskind-Hood, Cheryl AU - Robichaux, Chad AU - Downing, Karrie F. AU - Sarker, Abeed AB - International Classification of Disease (ICD) codes can accurately identify patients with certain congenital heart defects (CHDs). In ICD-defined CHD data sets, the code for secundum atrial septal defect (ASD) is the most common, but it has a low positive predictive value for CHD, potentially resulting in the drawing of erroneous conclusions from such data sets. Methods with reduced false positive rates for CHD among individuals captured with the ASD ICD code are needed for public health surveillance. AB - We propose a two-level classification system, which includes a CHD and an ASD classification model, to categorize cases with an ASD ICD code into three groups: ASD, other CHD, or no CHD (including patent foramen ovale). In the proposed approach, a machine learning model that leverages structured data is combined with a text classification system. We compare performances for three text classification strategies: support vector machines (SVMs) using text-based features, a robustly optimized Transformer-based model (RoBERTa), and a scalable tree boosting system using non-text-based features (XGBoost). AB - Using SVM for both CHD and ASD resulted in the best performance for the ASD and no CHD group, achieving F AB - scores of 0.53 (±0.05) and 0.78 (±0.02), respectively. XGBoost for CHD and SVM for ASD classification performed best for the other CHD group (F AB - score: 0.39 [±0.03]). AB - This study demonstrates that it is feasible to use patients' clinical notes and machine learning to perform more fine-grained classification compared to ICD codes, particularly with higher PPV for CHD. The proposed approach can improve CHD surveillance. AB - Author manuscript AN - cdc:261631 C4 - PMC11955907 DO - https://doi.org/10.1002/bdr2.2451 IS - 3 J2 - Birth Defects Research KW - International Classification of Diseases KW - Heart Defects, Congenital KW - Electronic Health Records KW - Humans KW - Natural Language Processing KW - Support Vector Machine KW - Machine Learning KW - Heart Septal Defects, Atrial KW - atrial septal defect KW - birth defects KW - congenital heart disease KW - natural language processing KW - Humans KW - Natural Language Processing KW - Machine Learning KW - Electronic Health Records KW - Heart Septal Defects, Atrial KW - International Classification of Diseases KW - Support Vector Machine KW - Heart Defects, Congenital LA - eng PY - 2025 T2 - Birth Defects Research T2 - Birth Defects Research, 2025, v. 117, no. 3 TI - Machine Learning and Natural Language Processing to Improve Classification of Atrial Septal Defects in Electronic Health Records. VL - 117 UR - https://stacks.cdc.gov/view/cdc/261631 ER -
Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022.

Emerson, Brian ;

Tao, Guoyu

May 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 5

Syphilis cases continue to climb in the United States, with a 159% increase among women between 2018 and 2022. Congenital syphilis (CS) cases continued along the same trajectory, with a 183% increase over the same time frame. Adherence to the screening guidelines may assist in reducing this trend. Our analysis aimed to determine the proportion of c ...

10/09/2026

Supporting Files

Title : Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022. Personal Author(s) : Emerson, Brian;Tao, Guoyu;Hufstetler, Kaitlin;Cramer, Ryan;Pearson, William S.; Published Date : May 2025 Pages in Document : 295-303 (20 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 5 DOI : https://doi.org/10.1097/OLQ.0000000000002089 Journal Title : Sexually Transmitted Diseases
Emerson, B., Tao, G., Hufstetler, K., Cramer, R., & Pearson, W. S. (2025). Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022. Sexually Transmitted Diseases, 52(5). https://doi.org/10.1097/OLQ.0000000000002089

Emerson, Brian, Guoyu Tao, Kaitlin Hufstetler, Ryan Cramer, and William S. Pearson. "Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022." Sexually Transmitted Diseases 52, no. 5 (2025). https://doi.org/10.1097/OLQ.0000000000002089.

Emerson, Brian, et al. "Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022." Sexually Transmitted Diseases, vol. 52, no. 5, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002089.
Export RIS Citation Information. TY - Journal Article AU - Emerson, Brian AU - Tao, Guoyu AU - Hufstetler, Kaitlin AU - Cramer, Ryan AU - Pearson, William S. AB - Syphilis cases continue to climb in the United States, with a 159% increase among women between 2018 and 2022. Congenital syphilis (CS) cases continued along the same trajectory, with a 183% increase over the same time frame. Adherence to the screening guidelines may assist in reducing this trend. Our analysis aimed to determine the proportion of commercially insured women receiving syphilis screening during pregnancy. AB - We analyzed the 2022 Merative MarketScan Database containing commercially insured medical claims to determine syphilis screening rates among insured pregnant women aged 18 to 49 years, insured for 8 months before childbirth. Screening events were classified into 3 categories: first (1-13 weeks), second (14-27 weeks), and third (28+ weeks). Percentages and odds ratios were calculated for pregnancy categories by age category, trimester, Centers for Medicare & Medicaid Services regions, employment, and type of health insurance. AB - Of the 170,005 pregnant women in the sample, 79.6% were screened for syphilis at least once, and 95.1% resided in a state requiring syphilis testing during pregnancy. The highest percentage of pregnant women was screened during the third trimester, and the majority of those screened received at least 2 tests during pregnancy. Women in states with laws had 14% greater odds for receiving any screening during pregnancy. AB - Despite Centers for Disease Control and Prevention syphilis screening recommendations, only 79.6% received screening among this insured population. Effective communication on the importance of syphilis screening for all medical providers and their patients may increase the screening rates and decrease the incidence of CS. AB - Author manuscript AN - cdc:261630 C4 - PMC12188607 DO - https://doi.org/10.1097/OLQ.0000000000002089 IS - 5 J2 - Sexually Transmitted Diseases KW - Pregnancy KW - Adolescent KW - Female KW - Mass Screening KW - Insurance Claim Review KW - Insurance, Health KW - Young Adult KW - Pregnancy Complications, Infectious KW - Syphilis KW - Databases, Factual KW - Syphilis, Congenital KW - Humans KW - Middle Aged KW - Adult KW - Humans KW - Female KW - Pregnancy KW - Adult KW - Syphilis KW - Adolescent KW - Mass Screening KW - Pregnancy Complications, Infectious KW - Young Adult KW - Middle Aged KW - Insurance, Health KW - Databases, Factual KW - Syphilis, Congenital KW - Insurance Claim Review LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 5 TI - Syphilis Screening During Pregnancy in 18- to 49-Year-Old Women in Commercially Insured Claims Data, 2022. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261630 ER -
Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023.

Balta, Victoria A. ;

Bressler, Sara

October 2025 | The Journal of Infectious Diseases, 2025, v. 232, no. 4

We describe the epidemiology of invasive group B streptococcal (GBS) disease among nonpregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases of invasive GBS disease were reported for an age-adjusted annual incidence of 9.1 (95% confidence interval [CI], 8.5-9.7) cases per 100 000 adults. Incidence increased 1.9-fold ( ...

10/09/2026

Supporting Files

Title : Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023. Personal Author(s) : Balta, Victoria A.;Bressler, Sara;Massay, Stephanie;Orell, Laurie;Reasonover, Alisa;Harker-Jones, Marcella;Kretz, Tony;Fischer, Marc;McLaughlin, Joseph;Steinberg, Jonathan; Published Date : October 2025 Pages in Document : e580-e584 (10 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 232, no. 4 DOI : https://doi.org/10.1093/infdis/jiaf055 Journal Title : The Journal of Infectious Diseases
Balta, V. A., Bressler, S., Massay, S., Orell, L., Reasonover, A., Harker-Jones, M., Kretz, T., Fischer, M., McLaughlin, J., & Steinberg, J. (2025). Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023. The Journal of Infectious Diseases, 232(4). https://doi.org/10.1093/infdis/jiaf055

Balta, Victoria A., Sara Bressler, Stephanie Massay, Laurie Orell, Alisa Reasonover, Marcella Harker-Jones, Tony Kretz, Marc Fischer, Joseph McLaughlin, and Jonathan Steinberg. "Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023." The Journal of Infectious Diseases 232, no. 4 (2025). https://doi.org/10.1093/infdis/jiaf055.

Balta, Victoria A., et al. "Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023." The Journal of Infectious Diseases, vol. 232, no. 4, 2025. Stacks. https://doi.org/10.1093/infdis/jiaf055.
Export RIS Citation Information. TY - Journal Article AU - Balta, Victoria A. AU - Bressler, Sara AU - Massay, Stephanie AU - Orell, Laurie AU - Reasonover, Alisa AU - Harker-Jones, Marcella AU - Kretz, Tony AU - Fischer, Marc AU - McLaughlin, Joseph AU - Steinberg, Jonathan AB - We describe the epidemiology of invasive group B streptococcal (GBS) disease among nonpregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases of invasive GBS disease were reported for an age-adjusted annual incidence of 9.1 (95% confidence interval [CI], 8.5-9.7) cases per 100 000 adults. Incidence increased 1.9-fold (95% CI, 1.6-2.2) between 2004-2013 and 2014-2023. Adults aged ≥65 years had a 4.4-fold higher risk of invasive disease compared to younger adults, and 47% of adults with invasive GBS had diabetes. Health care providers should be aware of populations at increased risk, potentially allowing for more prompt treatment. AB - Author manuscript AN - cdc:261629 C4 - PMC12353656 DO - https://doi.org/10.1093/infdis/jiaf055 IS - 4 J2 - The Journal of Infectious Diseases KW - Female KW - Streptococcal Infections KW - Diabetes Mellitus KW - Aged KW - Young Adult KW - Aged, 80 and over KW - Age Factors KW - Risk Factors KW - Incidence KW - Male KW - Humans KW - Middle Aged KW - Streptococcus agalactiae KW - Adult KW - Streptococcus agalactiae KW - Alaska KW - adult KW - surveillance KW - public health KW - incidence KW - Incidence KW - Streptococcal Infections KW - Streptococcus agalactiae KW - Risk Factors KW - Humans KW - Male KW - Female KW - Young Adult KW - Adult KW - Middle Aged KW - Aged KW - Aged, 80 and over KW - Age Factors KW - Diabetes Mellitus LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 232, no. 4 TI - Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023. VL - 232 UR - https://stacks.cdc.gov/view/cdc/261629 ER -
Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis.

Swartwood, Nicole A. ;

Cohen, Ted

February 2026 | Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 81, no. 6

Tuberculosis (TB) notifications and deaths in the United States fluctuated substantially during the coronavirus disease 2019 (COVID-19) pandemic. We analyzed multiple data sources to understand the factors contributing to these changes and estimated future TB trends.We identified 4 mechanisms potentially contributing to observed TB trends during 20 ...

10/09/2026

Supporting Files

Title : Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis. Personal Author(s) : Swartwood, Nicole A.;Cohen, Ted;Marks, Suzanne M.;Hill, Andrew N.;Beeler Asay, Garrett R.;Self, Julie;Feng, Pei-Jean I.;Horsburgh, C. Robert;Salomon, Joshua A.;Menzies, Nicolas A; Published Date : February 2026 Pages in Document : e659-e667 (16 pdf pages) Source : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 81, no. 6 DOI : https://doi.org/10.1093/cid/ciaf092 Journal Title : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Swartwood, N. A., Cohen, T., Marks, S. M., Hill, A. N., Beeler Asay, G. R., Self, J., Feng, P. J. I., Horsburgh, C. R., Salomon, J. A., & Menzies, N. A. (2026). Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 81(6). https://doi.org/10.1093/cid/ciaf092

Swartwood, Nicole A., Ted Cohen, Suzanne M. Marks, Andrew N. Hill, Garrett R. Beeler Asay, Julie Self, Pei-Jean I. Feng, C. Robert Horsburgh, Joshua A. Salomon, and Nicolas A Menzies. "Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 81, no. 6 (2026). https://doi.org/10.1093/cid/ciaf092.

Swartwood, Nicole A., et al. "Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 81, no. 6, 2026. Stacks. https://doi.org/10.1093/cid/ciaf092.
Export RIS Citation Information. TY - Journal Article AU - Swartwood, Nicole A. AU - Cohen, Ted AU - Marks, Suzanne M. AU - Hill, Andrew N. AU - Beeler Asay, Garrett R. AU - Self, Julie AU - Feng, Pei-Jean I. AU - Horsburgh, C. Robert AU - Salomon, Joshua A. AU - Menzies, Nicolas A AB - Tuberculosis (TB) notifications and deaths in the United States fluctuated substantially during the coronavirus disease 2019 (COVID-19) pandemic. We analyzed multiple data sources to understand the factors contributing to these changes and estimated future TB trends. AB - We identified 4 mechanisms potentially contributing to observed TB trends during 2020-2023: immigration, respiratory contact rates, rates of accurate diagnosis and treatment initiation, and mortality rates for persons experiencing TB disease. We employed a Bayesian approach to synthesize evidence on how these mechanisms changed during the pandemic and how they might have combined to produce observed 2020-2023 TB data, using a transmission-dynamic model to link mechanisms to TB outcomes. We also simulated a no-pandemic-counterfactual scenario that assumed mechanisms followed pre-pandemic trends. We estimated TB outcomes associated with the pandemic until 2035 to capture lagged effects. We evaluated additional scenarios to estimate the individual effect of each mechanism. AB - Over 2020-2035, we estimate an additional 2784 (95% uncertainty interval: 2164-3461) TB notifications and 1138 (1076-1201) TB deaths in the United States associated with changes occurring during the COVID-19 pandemic. Mechanisms had offsetting effects-decreases in TB diagnosis rates led to more TB deaths and notifications, while reductions in contact rates reduced TB deaths and notifications. Immigration changes initially reduced TB deaths, but increased deaths and notifications over time. Higher TB mortality rates increased TB deaths but decreased TB notifications. AB - Although direct impacts of the COVID-19 pandemic occurred between 2020 and 2023, these changes may continue to influence TB incidence and mortality in future years. AB - Author manuscript AN - cdc:261628 C4 - PMC12353213 DO - https://doi.org/10.1093/cid/ciaf092 IS - 6 J2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America KW - Pandemics KW - Bayes Theorem KW - SARS-CoV-2 KW - Tuberculosis KW - Humans KW - COVID-19 KW - Tuberculosis KW - COVID-19 KW - mathematical modeling KW - United States KW - Humans KW - COVID-19 KW - Bayes Theorem KW - Tuberculosis KW - SARS-CoV-2 KW - Pandemics LA - eng PY - 2026 T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 81, no. 6 TI - Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: a Bayesian Analysis. VL - 81 UR - https://stacks.cdc.gov/view/cdc/261628 ER -
Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital.

Redmond, Sarah N. ;

Cadnum, Jennifer L.

June 2025 | Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 80, no. 5

There have been several recent reports of Clostridioides difficile infection (CDI) due to isolates with reduced fidaxomicin susceptibility (minimum inhibitory concentration [MIC] ≥ 2 µg/mL). However, the clinical implications are uncertain because fidaxomicin achieves high concentrations in the intestinal tract.In an acute care hospital, we conduct ...

10/09/2026

Supporting Files

Title : Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital. Personal Author(s) : Redmond, Sarah N.;Cadnum, Jennifer L.;Jencson, Annette L.;Kaple, Claire E.;Wilson, Brigid M.;Skinner, Andrew M.;Gargis, Amy S.;Hwang, Munok;Choi, Hosoon;Chatterjee, Piyali;Jinadatha, Chetan;Donskey, Curtis J.; Published Date : June 2025 Pages in Document : 984-991 (16 pdf pages) Source : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 80, no. 5 DOI : https://doi.org/10.1093/cid/ciaf028 Journal Title : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Redmond, S. N., Cadnum, J. L., Jencson, A. L., Kaple, C. E., Wilson, B. M., Skinner, A. M., Gargis, A. S., Hwang, M., Choi, H., Chatterjee, P., Jinadatha, C., & Donskey, C. J. (2025). Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 80(5). https://doi.org/10.1093/cid/ciaf028

Redmond, Sarah N., Jennifer L. Cadnum, Annette L. Jencson, Claire E. Kaple, Brigid M. Wilson, Andrew M. Skinner, and Amy S. Gargis, et al.. "Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 80, no. 5 (2025). https://doi.org/10.1093/cid/ciaf028.

Redmond, Sarah N., et al. "Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 80, no. 5, 2025. Stacks. https://doi.org/10.1093/cid/ciaf028.
Export RIS Citation Information. TY - Journal Article AU - Redmond, Sarah N. AU - Cadnum, Jennifer L. AU - Jencson, Annette L. AU - Kaple, Claire E. AU - Wilson, Brigid M. AU - Skinner, Andrew M. AU - Gargis, Amy S. AU - Hwang, Munok AU - Choi, Hosoon AU - Chatterjee, Piyali AU - Jinadatha, Chetan AU - Donskey, Curtis J. AB - There have been several recent reports of Clostridioides difficile infection (CDI) due to isolates with reduced fidaxomicin susceptibility (minimum inhibitory concentration [MIC] ≥ 2 µg/mL). However, the clinical implications are uncertain because fidaxomicin achieves high concentrations in the intestinal tract. AB - In an acute care hospital, we conducted a 3-year cohort study of patients with CDI to determine the frequency of infection with isolates with reduced fidaxomicin susceptibility and the impact on response to fidaxomicin treatment. Stool specimens were cultured for C. difficile, and susceptibility testing was performed using agar dilution. Whole-genome sequencing was used to identify mutations associated with reduced fidaxomicin susceptibility and to determine relatedness of isolates. For genomically related susceptible and reduced susceptibility isolates from the same patient, we compared rates of growth, sporulation, and toxin production. AB - Of 108 fidaxomicin-treated patients, 6 (5.6%) were infected with isolates that possessed reduced fidaxomicin susceptibility (MICs 8-32 µg/mL), including 3 with initially susceptible isolates followed by clinical failure with subsequent recovery of genomically related isolates with reduced susceptibility. Isolates with reduced fidaxomicin susceptibility harbored mutations in RNA polymerase associated with reduced susceptibility and exhibited reduced toxin production, and 20% to 40% of isolates tested had reduced growth and/or sporulation in comparison with susceptible isolates. Three patients were infected with genomically indistinguishable ribotype 097 isolates with reduced fidaxomicin susceptibility. AB - Our findings highlight the potential for the emergence on therapy of clinically relevant reduced fidaxomicin susceptibility in C. difficile and its spread via transmission to other patients. AB - Author manuscript AN - cdc:261627 C4 - PMC13460438 DO - https://doi.org/10.1093/cid/ciaf028 IS - 5 J2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America KW - Female KW - Clostridioides difficile KW - Clostridium Infections KW - Aged KW - Aged, 80 and over KW - Cohort Studies KW - Fidaxomicin KW - Hospitals KW - Feces KW - Male KW - Middle Aged KW - Humans KW - Anti-Bacterial Agents KW - Whole Genome Sequencing KW - Drug Resistance, Bacterial KW - Microbial Sensitivity Tests KW - Mutation KW - Clostridioides difficile KW - fidaxomicin KW - susceptibility KW - transmission KW - whole-genome sequencing KW - Humans KW - Fidaxomicin KW - Clostridioides difficile KW - Clostridium Infections KW - Anti-Bacterial Agents KW - Microbial Sensitivity Tests KW - Male KW - Female KW - Drug Resistance, Bacterial KW - Aged KW - Middle Aged KW - Cohort Studies KW - Aged, 80 and over KW - Whole Genome Sequencing KW - Feces KW - Hospitals KW - Mutation LA - eng PY - 2025 T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 80, no. 5 TI - Emergence and Spread of Clostridioides Difficile Isolates With Reduced Fidaxomicin Susceptibility in An Acute Care Hospital. VL - 80 UR - https://stacks.cdc.gov/view/cdc/261627 ER -
Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022.

Diesel, Jill C. ;

Cope, Anna

September 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 9

We evaluated whether sexually transmitted infection clinic visits and chlamydia/gonorrhea tests in 5 jurisdictions had returned to pre-coronavirus disease levels by 2022. Patient volume and chlamydia/gonorrhea testing have not returned to pre-coronavirus disease levels, especially among people younger than 30 years.

10/09/2026

Supporting Files

Title : Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022. Personal Author(s) : Diesel, Jill C.;Cope, Anna;Pugsley, River;Furness, Bryce;Rahman, Mohammad;Kent, James B.;Dunworth, Ashleigh;Lee, Gayoung;Davis, Nicole L.; Published Date : September 2025 Pages in Document : e56-e60 (10 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 9 DOI : https://doi.org/10.1097/OLQ.0000000000002150 Journal Title : Sexually Transmitted Diseases
Diesel, J. C., Cope, A., Pugsley, R., Furness, B., Rahman, M., Kent, J. B., Dunworth, A., Lee, G., & Davis, N. L. (2025). Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022. Sexually Transmitted Diseases, 52(9). https://doi.org/10.1097/OLQ.0000000000002150

Diesel, Jill C., Anna Cope, River Pugsley, Bryce Furness, Mohammad Rahman, James B. Kent, Ashleigh Dunworth, Gayoung Lee, and Nicole L. Davis. "Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022." Sexually Transmitted Diseases 52, no. 9 (2025). https://doi.org/10.1097/OLQ.0000000000002150.

Diesel, Jill C., et al. "Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022." Sexually Transmitted Diseases, vol. 52, no. 9, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002150.
Export RIS Citation Information. TY - Journal Article AU - Diesel, Jill C. AU - Cope, Anna AU - Pugsley, River AU - Furness, Bryce AU - Rahman, Mohammad AU - Kent, James B. AU - Dunworth, Ashleigh AU - Lee, Gayoung AU - Davis, Nicole L. AB - We evaluated whether sexually transmitted infection clinic visits and chlamydia/gonorrhea tests in 5 jurisdictions had returned to pre-coronavirus disease levels by 2022. Patient volume and chlamydia/gonorrhea testing have not returned to pre-coronavirus disease levels, especially among people younger than 30 years. AB - Author manuscript AN - cdc:261626 C4 - PMC12339214 DO - https://doi.org/10.1097/OLQ.0000000000002150 IS - 9 J2 - Sexually Transmitted Diseases KW - Adolescent KW - Female KW - Gonorrhea KW - Sexually Transmitted Diseases KW - Chlamydia Infections KW - SARS-CoV-2 KW - Male KW - Humans KW - Young Adult KW - COVID-19 KW - Adult KW - chlamydia KW - gonorrhea KW - screening KW - STI clinics KW - COVID KW - Humans KW - Chlamydia Infections KW - Gonorrhea KW - Adult KW - COVID-19 KW - Female KW - Sexually Transmitted Diseases KW - Male KW - Young Adult KW - SARS-CoV-2 KW - Adolescent LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 9 TI - Sexually Transmitted Infection and Chlamydia/Gonorrhea Testing Have Not Returned to Pre-COVID Levels, 5 U.S. Jurisdictions, 2018-2022. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261626 ER -
Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs.

Madera-Garcia, Valerie ;

Broz, Dita

May 2025 | Drug and Alcohol Dependence, 2025, v. 270

Medications for opioid use disorder (MOUD) are key to preventing opioid overdose. Despite the high risk of opioid overdose among recently incarcerated people who use drugs, missed opportunities for engagement in MOUD treatment persist in this population. We examined the association between unmet need for MOUD and non-fatal opioid overdose among rec ...

10/09/2026

Supporting Files

Title : Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs. Personal Author(s) : Madera-Garcia, Valerie;Broz, Dita;Baugher, Amy R.;Hershow, Rebecca B.;Dasgupta, Sharoda;Asher, Alice;Hefferon, Rose;Worthington, Nancy;Cha, Susan; Published Date : May 2025 Pages in Document : 112634 (11 pdf pages) Source : Drug and Alcohol Dependence, 2025, v. 270 DOI : https://doi.org/10.1016/j.drugalcdep.2025.112634 Journal Title : Drug and Alcohol Dependence
Madera-Garcia, V., Broz, D., Baugher, A. R., Hershow, R. B., Dasgupta, S., Asher, A., Hefferon, R., Worthington, N., & Cha, S. (2025). Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs. Drug and Alcohol Dependence, 270. https://doi.org/10.1016/j.drugalcdep.2025.112634

Madera-Garcia, Valerie, Dita Broz, Amy R. Baugher, Rebecca B. Hershow, Sharoda Dasgupta, Alice Asher, Rose Hefferon, Nancy Worthington, and Susan Cha. "Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs." Drug and Alcohol Dependence 270 (2025). https://doi.org/10.1016/j.drugalcdep.2025.112634.

Madera-Garcia, Valerie, et al. "Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs." Drug and Alcohol Dependence, vol. 270, 2025. Stacks. https://doi.org/10.1016/j.drugalcdep.2025.112634.
Export RIS Citation Information. TY - Journal Article AU - Madera-Garcia, Valerie AU - Broz, Dita AU - Baugher, Amy R. AU - Hershow, Rebecca B. AU - Dasgupta, Sharoda AU - Asher, Alice AU - Hefferon, Rose AU - Worthington, Nancy AU - Cha, Susan AB - Medications for opioid use disorder (MOUD) are key to preventing opioid overdose. Despite the high risk of opioid overdose among recently incarcerated people who use drugs, missed opportunities for engagement in MOUD treatment persist in this population. We examined the association between unmet need for MOUD and non-fatal opioid overdose among recently incarcerated people who inject drugs (PWID) and assessed prevalence of non-fatal opioid overdose by selected characteristics. AB - We analyzed 2022 data from the National HIV Behavioral Surveillance (NHBS) system among PWID from 20 large U.S. cities. Adjusted prevalence ratios (aPR) and 95 % confidence intervals (95 % CI) were calculated to examine the association between unmet need for MOUD and non-fatal opioid overdose. AB - Among 1648 recently incarcerated PWID, 28 % reported an unmet need for MOUD and 39 % reported a non-fatal opioid-involved overdose in the past 12 months. Experiencing homelessness in the last 12 months (aPR=1.43, 95 % CI=1.27-1.61) and living in the Midwest region of the U.S. (aPR=1.18, 95 % CI=1.01-1.38) were significantly associated with reporting a non-fatal opioid overdose. Recently incarcerated PWID with an unmet need for MOUD were 1.4 times as likely to report a non-fatal opioid overdose in the past 12 months (50 %; aPR=1.42, 95 % CI=1.29-1.56) compared with recently incarcerated PWID without an unmet need for MOUD (35 %). AB - Unmet need for MOUD was significantly associated with non-fatal opioid overdose among PWID who were incarcerated in the past 12 months, suggesting the need to investigate specific strategies to improve to MOUD treatment among recently incarcerated PWID. AB - Author manuscript AN - cdc:261625 C4 - PMC12403188 DO - https://doi.org/10.1016/j.drugalcdep.2025.112634 J2 - Drug and Alcohol Dependence KW - Female KW - Opioid-Related Disorders KW - Young Adult KW - Prisoners KW - Opiate Overdose KW - Prevalence KW - Male KW - Middle Aged KW - Humans KW - Drug Overdose KW - Adult KW - Substance Abuse, Intravenous KW - Health Services Needs and Demand KW - medications for opioid use disorder KW - non-fatal opioid-related overdose KW - National HIV Behavioral Surveillance KW - drug injection KW - overdose prevention KW - Humans KW - Male KW - Adult KW - Female KW - Opioid-Related Disorders KW - Opiate Overdose KW - Prisoners KW - Substance Abuse, Intravenous KW - Middle Aged KW - Young Adult KW - Health Services Needs and Demand KW - Prevalence KW - Drug Overdose LA - eng PY - 2025 T2 - Drug and Alcohol Dependence T2 - Drug and Alcohol Dependence, 2025, v. 270 TI - Non-fatal Opioid Overdose and Unmet Need For Medications For Opioid Use Disorder Among Recently Incarcerated People Who Inject Drugs. VL - 270 UR - https://stacks.cdc.gov/view/cdc/261625 ER -
The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association?

Frank, Madeline ;

Austin, Anna E.

February 24, 2026 | Academic Pediatrics, 2026, v. 25, no. 4

The aims of this nationally representative cross-sectional study were to examine 1) the association of food hardship with family resilience and connection among families with children ages 6 to 17 years and 2) whether participation in Supplemental Nutrition Assistance Program (SNAP) benefits modified this association.We used 2019-21 data from the N ...

10/09/2026

Supporting Files

Title : The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association? Personal Author(s) : Frank, Madeline;Austin, Anna E.; Published Date : February 24, 2026 Pages in Document : 102807 (16 pdf pages) Source : Academic Pediatrics, 2026, v. 25, no. 4 DOI : https://doi.org/10.1016/j.acap.2025.102807 Journal Title : Academic Pediatrics
Frank, M., & Austin, A. E. (2026). The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association?. Academic Pediatrics, 25(4). https://doi.org/10.1016/j.acap.2025.102807

Frank, Madeline and Anna E. Austin. "The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association?." Academic Pediatrics 25, no. 4 (2026). https://doi.org/10.1016/j.acap.2025.102807.

Frank, Madeline, and Anna E. Austin "The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association?." Academic Pediatrics, vol. 25, no. 4, 2026. Stacks. https://doi.org/10.1016/j.acap.2025.102807.
Export RIS Citation Information. TY - Journal Article AU - Frank, Madeline AU - Austin, Anna E. AB - The aims of this nationally representative cross-sectional study were to examine 1) the association of food hardship with family resilience and connection among families with children ages 6 to 17 years and 2) whether participation in Supplemental Nutrition Assistance Program (SNAP) benefits modified this association. AB - We used 2019-21 data from the National Survey of Children's Health. We conducted multivariable generalized linear regression to calculate risk ratios (RRs) and 95% confidence intervals (CIs) examining the association of food hardship with an established measure of family resilience and connection. Then, among households with incomes <200% of the federal poverty level (FPL), we examined whether the association of food hardship with family resilience and connection differed among households participating and not participating in SNAP. We adjusted analyses for household characteristics and participation in other social safety net programs. AB - Families who experienced food hardship were less likely (RR = 0.73, 95% CI 0.69, 0.76) to have high family resilience and connection compared to families who did not experience food hardship. SNAP participation did not modify this association among households with incomes <200% FPL (RR = 0.71, 95% CI 0.65, 0.78 for SNAP-participating households; RR = 0.71, 95% CI 0.65, 0.77 for nonparticipating households). AB - Results add to evidence demonstrating that food hardship is a risk factor for lower family resilience and connection. Results highlight the need for further programs and policies, in addition to SNAP, to support families experiencing food hardship and promote family resilience and connection. AB - Author manuscript AN - cdc:261624 C4 - PMC12930788 DO - https://doi.org/10.1016/j.acap.2025.102807 IS - 4 J2 - Academic Pediatrics KW - Adolescent KW - Family KW - Female KW - Family Characteristics KW - Poverty KW - Resilience, Psychological KW - Linear Models KW - Child KW - Cross-Sectional Studies KW - Food Insecurity KW - Male KW - Food Assistance KW - Humans KW - family KW - family connection KW - food hardship KW - resilience KW - Supplemental Nutrition Assistance Program KW - Humans KW - Food Assistance KW - Child KW - Female KW - Male KW - Cross-Sectional Studies KW - Adolescent KW - Resilience, Psychological KW - Poverty KW - Food Insecurity KW - Family KW - Family Characteristics KW - Linear Models LA - eng PY - 2026 T2 - Academic Pediatrics T2 - Academic Pediatrics, 2026, v. 25, no. 4 TI - The Association of Food Hardship With Family Resilience and Connection: Does Participation in Supplemental Nutrition Assistance Program Modify This Association? VL - 25 UR - https://stacks.cdc.gov/view/cdc/261624 ER -

Previous Page Previous

621 - 640 / 1970

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov